Investing Profile

Jill carroll

Principal at S.R. One Ltd

Your Intro Paths to Jill carroll

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Jill is a member of

Alex & Thiago Network

499 CONNECTIONS

Alex & Thiago Network

499 CONNECTIONS

Duke University Network

258 CONNECTIONS

Duke University Network

258 CONNECTIONS

Mercer Management Consulting Network

18 CONNECTIONS

Find Jill carroll on

Current Investing Position

Investments On Record

Jill carroll's Investments On Record (8)

Company	StageDateRound Size	Total Raised
AirNexis Therapeutics	Series AJan 2026$200M	$200M
Poplar Therapeutics	Series AJan 2026$50M	$50M
Co-investors: Helen Kim (The Column Group)
Avalyn Pharma	Series DJul 2025$100M Series CSep 2023$180M	$310M
Co-investors: Robert Mittendorff (B Capital Group), Heather Preston (Oxonian Ventures )
Odyssey Therapeutics	Series BOct 2022$170M Series ADec 2021$220M	$700M
Co-investors: Elena Viboch (General Catalyst), Jonathan MacQuitty (Lightspeed Venture Partners), Lorence Kim (Third Rock Ventures), Carl Gordon (OrbiMed Advisors), Brenton Fargnoli (AlleyCorp), Nan Li (6 Dimensions Capital), Ravi Mhatre (Kamanu Ventures & Lightspeed Venture Partners Scout)
HotSpot Therapeutics	Series CNov 2021$100M Series BMay 2020$65M	$210M
Co-investors: Graziano Seghezzi (Sofinnova Partners), Bruce Booth (Atlas Venture), Fouad Azzam (EQT Life Sciences), Ash Khanna (SV Health Investors)
Arch Oncology	Series AAug 2016$86M	$190M
Co-investors: John McKearn (RiverVest Venture Partners), Peter Moldt (Novo Ventures), Carole Nuechterlein (F.Hoffmann-La Roche)
Second Genome	Series BApr 2016$51M	$58M
Co-investors: Mike Carusi (Lightstone Ventures), Jason Lettmann (Morgenthaler Ventures), Carole Nuechterlein (F.Hoffmann-La Roche)
AGTC	Series BNov 2012$38M	$38M
Co-investors: Bill Harrington (Osage University Partners (OUP)), Ed Hurwitz (MPM Capital)

Jill carroll's Experience

Principal S.R. One Ltd2011 - Present

Consultant Alex & ThiagoPresent

Director, Market Analysis Alex & ThiagoPresent

Principal SR One Capital ManagementPresent

Board Member Phylaxis BiosciencesPresent

Partner SR One Capital ManagementPresent

VP, Corporate Development Limerick Biopharma2010 - 2011

Sr Director, Strategic Planning & Corporate Development Dynavax Technologies2004 - 2010

Director, Market Analysis Clearview Projects2001 - 2004

Consultant Mercer Management Consulting1999 - 2001

Jill carroll's Education

Johns Hopkins University MS Biochemistry

Duke University BS Chemistry

Duke University Bachelor's degree Chemistry

Investors who invest with Jill carroll

Scouts & Angels Affiliated With Jill carroll